English deutsch Impressum
Sitemap Disclaimer
Company Product Investor Relations Newsroom Careers Contact
 

Pipeline
Philosophy
RENCAREX®
REDECTANE®
MESUPRON®
WX−554
WX−037
Research Projects
Publications
For Patients

Research projects

WILEX’s three antibody-based projects are currently in the research phase. The aim is to identify a specific antibody that binds to each new target structure. These molecular targets of the antibodies play different roles in spreading cancer or are present on tumour cells.